Real-time enrollment status for this multiple sclerosis (ms) - relapsing-remitting clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:08 PM UTC
| NCT Number | NCT06629428 |
| Recruiting Status | Recruiting |
| Condition | Multiple Sclerosis (MS) - Relapsing-remitting |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Georgia State University |
| Last Updated on CT.gov | February 9, 2026 (Feb 9, 2026) |
As of July 16, 2026: Clinical trial NCT06629428 is currently recruiting participants. This early_phase1 study for multiple sclerosis (ms) - relapsing-remitting is actively seeking new participants at 2 locations across the United States. The study is sponsored by Georgia State University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06629428 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06629428 was last updated Feb 9, 2026 (February 9, 2026). HelloStudys verifies this status automatically.